Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ohkawa

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Japanese Journal of Cancer Research : Gann|November 1, 1994
Clinical usefulness of CYFRA assay in diagnosing lung cancer: measurement of serum cytokeratin fragmentY Sugama, S Kitamura, T Kawai, et al.
Hinyokika Kiyo. Acta Urologica Japonica|April 1, 1992
[Measurement of serum PSA values by DELFIA PSA and its clinical significance on diagnosis and follow-up of prostate cancer patients]M Kuriyama, N Esaki, S Yamada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1996
[Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit]H Sakahara, K Endo, K Torizuka, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Japanese Journal of Cancer Research : Gann|November 1, 1994
Clinical usefulness of CYFRA assay in diagnosing lung cancer: measurement of serum cytokeratin fragmentY Sugama, S Kitamura, T Kawai, et al.
Hinyokika Kiyo. Acta Urologica Japonica|April 1, 1992
[Measurement of serum PSA values by DELFIA PSA and its clinical significance on diagnosis and follow-up of prostate cancer patients]M Kuriyama, N Esaki, S Yamada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1996
[Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit]H Sakahara, K Endo, K Torizuka, et al.
Pageof 5